US Stock MarketDetailed Quotes

BCAB BioAtla

Watchlist
  • 3.090
  • -0.080-2.52%
Close May 7 16:00 ET
148.65MMarket Cap-1197P/E (TTM)

About BioAtla Company

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.

Company Profile

SymbolBCAB
Company NameBioAtla
Listing DateDec 16, 2020
Issue Price18.00
Founded2007
CEODr. Jay M. Short,PhD
MarketNASDAQ
Employees65
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11085 Torreyana Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-558-0708
Websitehttp://www.BioAtla.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jay M. Short,PhD
  • Chairman of the Board and Chief Executive Officer
  • 3.30M
  • Dr. Eric Sievers, M.D.
  • Chief Medical Officer
  • 1.32M
  • Christian Vasquez
  • Chief Accounting Officer, Controller and Corporate Secretary
  • --
  • Richard A. Waldron
  • Senior Vice President and Chief Financial Officer
  • 1.24M
  • Scott A. Smith
  • Director
  • 1.27M
  • Dr. Lawrence J. Steinman, M.D.
  • Independent Director
  • 161.19K
  • Dr. Susan Moran, M.D.
  • Independent Director
  • 158.19K
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 180.44K
  • Edward Williams
  • Independent Director
  • 168.94K
  • Sylvia McBrinn
  • Independent Director
  • 164.57K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg